Company Of The Day: Pfizer
What?
Pfizer (NYSE:PFE) stock rallied to all-time highs of about $54 per share last Friday, although it fell a bit to about $52.50 on Monday.
Why?
- After A 30% Fall In A Year Is Pfizer Stock A Better Pick Over Merck?
- Should You Pick Pfizer Stock At $30 After A 30% Fall In A Year?
- Should You Pick Pfizer Stock At $30?
- Down 25% In A Year Will Pfizer Stock Rebound To Its Pre-Inflation Shock Level?
- Will Pfizer Stock See Higher Levels Post Q1 Earnings?
- Is Pfizer Stock Undervalued At $40?
The gains come amid renewed fears of another surge in Covid-19 cases as a highly mutated variant of the novel coronavirus was discovered in southern Africa. This could translate into higher demand for Pfizer’s Covid-19 vaccine.
So What?
We still think PFE stock has a little more room to run. We value the stock at about $58 per share, about 11% ahead of the market price.
See Our Complete Analysis For Pfizer
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.
| Returns | Nov 2021 MTD [1] |
2021 YTD [1] |
2017-21 Total [2] |
| PFE Return | 21% | 42% | 61% |
| S&P 500 Return | 1% | 24% | 108% |
| Trefis MS Portfolio Return | N/A% | 48% | 301% |
[1] Month-to-date and year-to-date as of 11/30/2021
[2] Cumulative total returns since 2017